Skip to main content
Fig. 3 | BMC Endocrine Disorders

Fig. 3

From: Toxicity of insulin-derived amyloidosis: a case report

Fig. 3

Toxicity of insulin-derived amyloidosis in Cases 1–5. Two samples separately prepared from Case 5 (Case 5–1 and 5–2) in the HEK293T cell assay (a) and one sample (Case 5–2) in the HeLa cell assay (b) show significantly lower cell viability than the control. Error bars, SE; *, p < 0.05

Back to article page